{"product_id":"2025-psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines","title":"2025 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines (Videos with subtitles + Slides)","description":"\u003ch3\u003e2025 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines\u003c\/h3\u003e\n\u003ch3 class=\"activitysectionbold\"\u003eSpecialties\u003c\/h3\u003e\n\u003cem\u003eSpecialties \u003c\/em\u003e- Behavioral Care, Critical Care, General and Family Practice, Geriatric Medicine, Hematology, Integrative Medicine, Internal Medicine, Medical Oncology, Neurology, Nurse Anesthetist, Nurse Practitioner, Nursing, Pain Medicine, Psychiatry, Psychology, Social Work\u003cbr\u003e\u003ch3 class=\"activitysectionbold\"\u003eOverview\u003c\/h3\u003e\u003cbr\u003eClinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. \u003cstrong\u003ePsychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. \u003c\/strong\u003eFew oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology.\u003cbr\u003e\u003cbr\u003eEven when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses, and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.\u003cbr\u003e\u003cbr\u003eThis highly regarded annual course, co-sponsored by the MSK \u003cstrong\u003ePsycho-Oncology Education and Training Institute (POETI)\u003c\/strong\u003e, is designed to support non-prescribing psycho-oncology clinicians and psychiatrists new to Psycho-pharmaco-oncology. Oncologists, palliative care providers, advanced practice nurses, and oncology nurses will also find it invaluable.\u003cbr\u003e\u003cbr\u003eThe program emphasizes effective psychopharmacological interventions for key disorders and symptoms, including anxiety, depression, delirium, sleep dsisturbances, pain, fatigue, and changes in weight or appetite. Expert faculty will provide updates on the use of novel interventions including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain. Additionally, the vital role of clinical social work in delivering psychosocial support will be examined.\u003cbr\u003e\u003cbr\u003eParticipants will gain skills to recognize and differentiate psychological reactions to medical conditions or treatments, psychiatric manifestations of medical conditions or treatments, and medical presentations of psychiatric conditions. We'll also explore common medical complications associated with psychiatric conditions or their treatments.\u003cbr\u003e\u003cbr\u003eFoundational knowledge will be provided about medications used to alleviate Quality-of-Life symptoms that arise in the cancer setting from diagnosis to survivorship or end-of-life care and the interface of psychotherapy and medication management. We'll review why certain medications are used and why some are avoided, looking at potential benefits, unwanted side effects, and drug-drug interactions since you may be the first person to identify a serious adverse event. This program will enhance participants' ability to provide psychoeducation to patients regarding psychiatric medications.\u003cbr\u003e\u003cbr\u003eAttendees will receive access to an online syllabus after the course, which will include select PDFs of the faculty presentations (slides) and recorded videos.\u003cbr\u003e\u003ch3 class=\"activitysectionbold\"\u003eObjectives\u003c\/h3\u003e\u003cbr\u003eBy attending this program, learners will be able to:\u003cbr\u003e\u003col\u003e\n\u003cli\u003eDescribe basic psycho-pharmaco-oncology principles for understanding and treating anxiety, depression and delirium in people with cancer.\u003c\/li\u003e\n\u003cli\u003eIdentify the use of novel interventions including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain in people with cancer.\u003c\/li\u003e\n\u003cli\u003eDiscuss basic psycho-pharmaco-oncology principles for understanding and improving quality of life and psychiatric palliative care in people with cancer, including managing cognitive changes, insomnia, fatigue, poor appetite and weight loss, and pain.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eSchedule\u003c\/h3\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eSaturday, April 5, 2025\u003c\/h3\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"12u\"\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHandouts\u003c\/strong\u003e\u003cbr\u003e8:25AM - 8:40AM\u003cbr\u003eWilliam Breitbart, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDepressive Disorders\u003c\/strong\u003e\u003cbr\u003e8:45AM - 9:30AM\u003cbr\u003eAndrew J. Roth, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDelirium\u003c\/strong\u003e\u003cbr\u003e9:30AM - 10:15AM\u003cbr\u003eWilliam Breitbart, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnxiety Disorders\u003c\/strong\u003e\u003cbr\u003e10:30AM - 11:15AM\u003cbr\u003eAndrew J. Roth, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSleep Disorders\u003c\/strong\u003e\u003cbr\u003e11:15AM - 12:00PM\u003cbr\u003eYesne Alici, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCancer-Related Fatigue\u003c\/strong\u003e\u003cbr\u003e1:00PM - 1:45PM\u003cbr\u003eWilliam Breitbart, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePain\u003c\/strong\u003e\u003cbr\u003e1:45PM - 2:30PM\u003cbr\u003eNatalie Moryl, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWeight and Appetite Loss\u003c\/strong\u003e\u003cbr\u003e2:30PM - 3:00PM\u003cbr\u003eYesne Alici, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCancer and Cancer-Treatment Related Cognitive Changes\u003c\/strong\u003e\u003cbr\u003e3:15PM - 3:45PM\u003cbr\u003eYesne Alici, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNovel Psychopharmacologic Interventions in Oncology\u003c\/strong\u003e\u003cbr\u003e3:45PM - 4:15PM\u003cbr\u003eChristian Bjerre Real, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eKetamine and Esketamine for Depression\u003c\/strong\u003e\u003cbr\u003e4:15PM - 4:45PM\u003cbr\u003eErik Bengtsen, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCaring for the Whole Patient: The Role of Clinical Social Work in Psychosocial Support\u003c\/strong\u003e\u003cbr\u003e4:45PM - 5:15PM\u003cbr\u003eChristine Wilkins, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003e\u003c\/h3\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954494476386,"sku":"MED-AMB04554","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/2025-Psychopharmacology-in-Cancer-Care-An-Update-for-Clinicians-of-All-Disciplines.webp?v=1779377982","url":"https:\/\/meducourse.com\/products\/2025-psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines","provider":"Meducourse","version":"1.0","type":"link"}